Madhuri Bhat

Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia.

Ceterix Orthopaedics, Inc. develops novel surgical tools for arthroscopic procedures. It offers NovoStitch Pro Meniscal Repair System, a device designed to address complex meniscal tear patterns not adequately served by other repair systems. The company was founded by Justin Saliman and John G. McCutcheon in October 2010 and is headquartered in Fremont, CA.

Split Rock Partners LLC (Split Rock Partners) is a venture capital firm founded by Jim Simons, Michael Gorman, David Stassen. The firm is headquartered in Eden Prairie, Minnesota.

Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia.

Alloy Ventures, Inc. is an independent Venture Capital firm founded in 1984 by Craig C. Taylor, John F. Shoch and Tony Di Bona. The firm is headquartered in Palo Alto, California.

PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia.

OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia.

Baker Heart & Diabetes Institute owns and operates a medical research institute. The company is headquartered in Melbourne, Australia.

Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel.

Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Bone Health Technologies, Inc. manufactures medical devices for low bone mass. The company is headquartered in San Francisco, CA.

Springboard Enterprises, Inc. is a leading network of industry experts, investors, and innovators dedicated to building companies at scale led by women who are transforming industries in technology, life sciences, and healthcare. The non-profit company is based in Washington and has subsidiaries in the United States. Since 2000, over 890+ Springboard portfolio companies seeking investment and human capital for product development and expansion have created over $39.10b in value. With 225 exits to strategic acquirers, 27 IPOs, and 10 unicorns, Springboard entrepreneurs are transforming industries. The American company's mission is to accelerate the growth of women-led entrepreneurial companies through access to essential resources and a community of experts. Springboard is a network of entrepreneurs, investors, and advisors accelerating the success of women entrepreneurs in technology and life sciences. The company was founded by Kay Koplovitz, Amy Millman. Natalie Buford-Young has been the CEO of the company since 2020.

Huma.AI, Inc develops automation platform for the pharmaceutical and healthcare industry. The company was founded by Lana Feng, Gregory P. Kostello, and Chang Sung Yu and is headquartered in Palo Alto, CA.

Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia.

Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA.

Miramar Technologies, Inc. develops and provides medical devices for dermatologic medical conditions. It specializes in microwave energy positioned to be adopted for dermatologic conditions. The company was founded by Henry A. Plain Jr., Mark E. Deem and Steven Kim in 2006 and is headquartered in Half Moon Bay, CA.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

The Foundry LLC provides investment services to medical device companies. It includes the inventor partners of business development, product development and prototyping, market analysis and development, human resources and recruitment and intellectual property enterprise. The company was founded by Allan R Will and Henry A. Plain, Jr. in 1998 and is headquartered in Menlo Park, CA.

Medical Research Commercialisation Fund Trust invests in life science companies located in Australia. The fund focuses on companies operating in the fields of medical research institutes and allied research hospitals. It provides seed and early stage financing in project investment of up to $0.02 million, at the stage of company formation invests up to $4 million and also makes follow-on investments of up to $2 million. It seeks co-investment with other investors for technologies with larger capital requirements.

QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA.

Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

IDEO LP provides marketing, consulting, product development, and branding and designing services. It offers strategic services, including exploration, service design and transformation services. The company was founded by David M. Kelly, Mike Nuttall and Bill Moggridge in 1991 and is headquartered in Palo Alto, CA.